【摘 要】
:
OBJECTIVE Although the underlying mechanism is largely unknown, gut dysbiosis has emerged as a central initiator of obesity-related diseases including nonalcoholic fatty liver disease (NAFLD), type 2 diabetes and meta?bolic syndrome. The emerging evidence
【机 构】
:
Functional Metabolomic and Gut Microbiome Laboratory,Institute of Interdisciplinary Integrative Medi
论文部分内容阅读
OBJECTIVE Although the underlying mechanism is largely unknown, gut dysbiosis has emerged as a central initiator of obesity-related diseases including nonalcoholic fatty liver disease (NAFLD), type 2 diabetes and meta?bolic syndrome. The emerging evidence support the use of prebiotics like herb-derived polysaccharides for treating NAFLD by modulating gut microbiome. So, our study focused on the microbiota-dependent anti-NAFLD effect and the exact mechanisms of Astragalus polysaccharides (APS) extracted from Astragalus mongholicus Bunge in high-fat diet (HFD) fed mice. METHODS Co-housing experiment was used to assess the microbiota dependent anti-NAFLD effect of APS. Then, targeted metabolomics and metagenomics were adopted for determining short-chain fatty acids (SCFAs) and bacteria that were specifically enriched by APS. Further in vitro experiment was carried out to test the capacity of SCFAs-producing of identified bacterium. Finally, the anti-NAFLD efficacy of identified bacterium was tested in HFD fed mice. RESULTS Our results first demonstrated the anti-NAFLD effect of APS in HFD fed mice and the contribution of gut microbiota. Moreover, our results indicated that SCFAs, predominantly acetic acid were elevated in APS-supplemented mice and ex vivo experiment. Metagenomics revealed that D. vulgaris from Desulfovibrio genus was not only enriched by APS, but also a potent generator of acetic acid, which showed significant anti-NAFLD effects in HFD fed mice. In addition, D. vulgaris modulated the hepatic gene expression pattern of lipids metabolism, particularly suppressed hepatic fatty acid synthase (FASN) and CD36 protein expression. CONCLUSION APS enriched D. vulgaris is effective on attenuating hepatic steatosis possibly through producing acetic acid, and modulation on hepatic lipids metabolism in mice. Further studies are warranted to explore the long-term impacts of D. vulgaris on host metabolism and the underly?ing mechanism.
其他文献
中图分类号 R95;R969.3 文献标志码 A 文章编号 1001-0408(2021)21-2662-06 DOI 10.6039/j.issn.1001-0408.2021.21.17 摘 要 目的:为药师参与门诊抗菌药物管理以及促进门诊合理使用抗菌药物提供参考。方法:药师通过对我院使用的“逸曜合理用药管理软件”(简称“审方软件”)原有的抗菌药物使用规则进行梳理,并根据对抗菌药物
中圖分类号 R288 文献标志码 A 文章编号 1001-0408(2021)21-2668-05 DOI 10.6039/j.issn.1001-0408.2021.21.18 摘 要 目的:探讨江苏省门诊患者利用中医药服务行为的影响因素,为中医药服务的科学利用提供参考。方法:基于2018年《全国第六次卫生服务统计调查报告》中江苏省的相关数据,描述性分析江苏省1 617例门诊患者利用
中图分类号 R917 文献标志码 A 文章编号 1001-0408(2021)21-2631-04 DOI 10.6039/j.issn.1001-0408.2021.21.12 摘 要 目的:建立氣-质联用(GC-MS)法同时测定甘磷酸胆碱原料药中环氧氯丙烷、缩水甘油、3-氯-1,2-丙二醇等3种遗传毒性杂质的含量。方法:以4批甘磷酸胆碱原料药为检测样品。色谱柱为ZB-WAXplus
編者按:为深入学习贯彻习近平新时代中国特色社会主义思想,落实2021年全国宣传部长会议和全国卫生健康工作会议精神,聚焦中国共产党成立以来卫生健康事业历史进程中的重要决策、活动及成果,从不同角度和层面展现卫生健康事业发展的重要成就,我刊特从2021年7月起开设“党为人民谋健康的100年”专栏,从我刊实际出发,陆续推出一系列我国健康卫生事业与药学工作结合的相关文章,从而助力提高人民健康水平制度保障、坚
中圖分类号 R714.7;R984 文献标志码 A 文章编号 1001-0408(2021)21-2655-07 DOI 10.6039/j.issn.1001-0408.2021.21.16 摘 要 目的:系统评价米索前列醇对比缩宫素预防产后出血的临床有效性及安全性,为临床用药提供循证参考。方法:计算机检索中国知网、维普网、万方数据库、中国生物医学文献数据库、PubMed、Embas
中圖分类号 R285.5 文献标志码 A 文章编号 1001-0408(2021)21-2635-05 DOI 10.6039/j.issn.1001-0408.2021.21.13 摘 要 目的:研究延龄草总皂苷(TTM)对佐剂性关节炎模型大鼠的改善作用及机制。方法:将SD大鼠随机分为造模组(n=44)和空白组(n=6),造模组大鼠注射完全弗氏佐剂以复制佐剂性关节炎模型,空白组大鼠同
中圖分类号 R969.3 文献标志码 A 文章编号 1001-0408(2021)21-2672-05 DOI 10.6039/j.issn.1001-0408.2021.21.19 摘 要 目的:介绍临床药师在卡瑞利珠单抗致中毒性表皮坏死松解症(TEN)患者治疗过程中的作用,为类似不良反应的治疗提供参考。方法:临床药师参与1例卡瑞利珠单抗致中毒性表皮坏死松解症患者的治疗过程。该患者使
中图分类号 R285.5 文献标志码 A 文章编号 1001-0408(2021)21-2683-06 DOI 10.6039/j.issn.1001-0408.2021.21.21 摘 要 目的:综述积雪草苷(AS)的药理作用及机制,为AS新药开发和临床应用提供参考。方法:以“积雪草苷”“抗肿瘤”“抗炎”“asiaticoside” “anti-tumor” “anti-inflam
中圖分类号 R179;R985 文献标志码 A 文章编号 1001-0408(2021)21-2647-08 DOI 10.6039/j.issn.1001-0408.2021.21.15 摘 要 目的:汇总分析药物治疗儿童抽动障碍的系统评价研究证据,为临床实践提供循证参考。方法:计算机检索Medline、Embase、中国生物医学文献数据库、中国知网、维普中文科技期刊数据库、万方数据
中圖分类号 R730.6;R975+.4 文献标志码 A 文章编号 1001-0408(2021)21-2640-07 DOI 10.6039/j.issn.1001-0408.2021.21.14 摘 要 目的:探索可能导致帕洛诺司琼联合地塞米松预防化疗所致恶心呕吐(CINV)失败的危险因素,为合理选择和使用预防CINV的药物提供参考。方法:采用回顾性病例对照研究,以某三级肿瘤专科医